Stocktoria
Evolent Health, Inc. EVH
NYSE · XNYS · stock · Services-Management Services · website · IPO 2015-06-05
Evolent Health, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.9B | $2.6B | $2.0B | $1.4B | $908.0M |
| R&D expense | — | — | — | — | $15.5M |
| SG&A expense | $303.9M | $263.1M | $358.1M | $269.3M | $219.5M |
| Operating income | -$410.1M | -$40.5M | -$71.2M | $3.6M | -$42.4M |
| Interest expense | — | — | $54.2M | $15.6M | $25.4M |
| Income tax | -$126,000 | -$1.4M | -$89.4M | -$43.4M | $483,000 |
| Net income | -$534.5M | -$61.6M | -$113.0M | -$19.2M | -$37.6M |
| EPS (diluted) | $-5.07 | $-0.81 | $-1.28 | $-0.20 | $-0.44 |
| Operating cash flow | $38.8M | $18.8M | $142.6M | -$11.6M | $38.7M |
| Cash & equivalents | $151.9M | $104.2M | $192.8M | $188.2M | $266.3M |
| Total assets | $1.9B | $2.5B | $2.7B | $1.8B | $1.4B |
| Total liabilities | $1.5B | $1.4B | $1.4B | $957.9M | $725.8M |
| Shareholders' equity | $415.2M | $1.0B | $1.1B | $859.4M | $693.6M |
Source: SEC EDGAR filings · CIK 0001628908 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.